Eric A. Secemsky/LinkedIn
Sep 17, 2025, 16:32
Endovascular Today: Dr. Eric Secemsky Analyzes Impact of Paclitaxel Pause on Peripheral Artery Disease Care
Endovascular Today posted on LinkedIn:
”Eric A. Secemsky offers his thoughts on how the pause in paclitaxel use impacted the care of patients with lower extremity arterial occlusive disease and discusses observed clinical effects during that period. ”
Read more here.
Title: Exploring the Effects of the Paclitaxel Pause
Author: Eric A. Secemsky
Stay updated with Hemostasis Today.
-
Jun 12, 2026, 16:40Connie Montgomery about Last Night with Trialport and Global Genes
-
Jun 12, 2026, 16:20Tejas Ahire: When the Body’s Clotting System Goes Out of Control
-
Jun 12, 2026, 16:14Chokri Ben Lamine: EHA26 – SCD Curative Therapy Pathway
-
Jun 12, 2026, 16:13Talha Badar: Excellent Talk by Francesca Palandri on ET and PV at EHA 2026
-
Jun 12, 2026, 16:12Miguel Gómez Álvarez: The Evidence on Disease Burden in PNH
-
Jun 12, 2026, 16:11Shinya Goto: The Japanese Investigators Behind Tranexamic Acid
-
Jun 12, 2026, 16:10Rahul Kumar: Improved Chemotherapy Delivery Is Meaningful Only When It Improves Patient Outcomes
-
Jun 12, 2026, 15:24A Practical Guide to Living Well with ITP – ITP Support Association
-
Jun 12, 2026, 15:16Courtney Lawrence: The AABB Bulletin on Neonatal Red Blood Cell Transfusion and Mannitol Exposure is Now Released